Shares of AVITA Medical Inc. (RCEL) are down over 50% from their 52-week high of $14.16, recorded in January of this year, to trade around $7.
This therapeutic acute wound care company's flagship product is the RECELL System, an autologous cell harvesting device intended for use at the point of care by a trained health care professional. It enables the collection of a small skin sample, which is then used to create a suspension of Spray-On Skin Cells for treatment. The device is approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.